Methods for identification of modulatory compounds for the expression of the NES1 protein
AssigneeNew England Medical Center Hospitals, Inc.
InventorVimla Band
Life of this patent
Estimating the term…
Abstract
The expression and purification of normal epithelial specific polypeptide (NES 1) which is expressed in normal cells, but not in radiation transformed cells, are described. Both the DNA sequence encoding the NES1 and the corresponding amino acid sequence are disclosed. Also, disclosed are methods for carcinoma detection and treatment using the NES1 as well as methods of identifying compounds modulating the expression and activity of NES1.
Claims5
A method of identifying a modulatory compound which is capable of increasing the expression of a Normal Epithelial Specific 1 (NES1) gene, said NES1 gene encoding a polypeptide having the sequence set forth in FIG. 10 (SEQ ID NO:
- 1), said method comprising (a) providing a cell expressing said NES1 gene, and (b) contacting said cell with a candidate compound, an increase in said NES1 expression following contact with said candidate compound identifying a modulatory compound.
A method of identifying a modulatory compound which is capable of increasing NES1 protease activity, wherein said NES1 protease has the sequence set forth in FIG. 10 (SEQ ID NO:
- 1), said method comprising (a) providing a cell expressing said NES1 protease;
- and (b) contacting said cell with a candidate compound, an increase in said NES1 protease activity following contact with said candidate compound identifying a modulatory compound.
Dependencies are inferred from the claim text.